Sanofi trades Seprafilm unit to Baxter for $350M in cash ahead of strategy launch

Sanofi has moved to offload its Seprafilm surgical barrier business, setting up a large infusion of cash for early next year as its new CEO prepares to unveil his new strategic priorities for the company. The French drugmaker aims to trade the unit to Baxter International in return for $350 million.